Bridge Bank extended a venture term loan to Deep Lens, a Columbus, OH-based software company focused on accelerating clinical trial recruitment for cancer patients. The company is venture-backed by Northpond Ventures, Sierra Ventures, Rev1 Ventures and Tamarind Hill.
“We view this additional financing as a vote of confidence for our business strategy as we continue to grow and expand,” Simon Arkell, president and co-founder of Deep Lens, said. “Success requires teamwork and we’re delighted to have a business partner like Bridge Bank. The Bridge team really took the time to understand our business proposition.”
“Deep Lens has developed a highly disruptive solution for rapid patient identification in clinical trials,” Mark Breneman, senior vice president in Bridge Bank’s technology banking group, said. “We’re very pleased to be working with the Deep Lens team and look forward to supporting their continued growth as they deploy a solution that will truly save lives.”
Bridge Bank is a division of Western Alliance Bank.
